Celcuity Inc. (CELC)

Orchard Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	16.48	22.51	30.66	24.57	84.29	11.64
Short-Term Investments	189.21	212.59	149.92	144.02	0.02	0.02
Cash & Short-Term Investments	205.69	235.1	180.58	168.59	84.31	11.66
Cash Growth	15.78%	30.19%	7.12%	99.97%	623.06%	-37.84%
Other Receivables	-	1.6	0.81	-	0.3	0.19
Receivables	-	1.6	0.81	-	0.3	0.19
Prepaid Expenses	-	7.03	8.92	-	0.72	0.32
Other Current Assets	11.91	0.84	0.28	6.6	0.02	-
Total Current Assets	217.6	244.57	190.59	175.19	85.35	12.17
Property, Plant & Equipment	0.53	0.55	0.63	0.51	0.55	0.79
Total Assets	218.13	245.12	191.22	175.7	85.91	12.96
Accounts Payable	9.93	9.37	5.08	2.63	1.51	0.22
Accrued Expenses	22.82	22.18	8.93	4.06	0.8	0.77
Current Portion of Leases	0.17	0.17	0.18	0.19	0.2	0.19
Total Current Liabilities	32.92	31.72	14.19	6.88	2.51	1.19
Long-Term Debt	98.53	97.73	37.04	34.98	14.63	-
Long-Term Leases	0.01	0.05	0.23	0.06	0.06	0.07
Total Liabilities	131.46	129.5	51.45	41.93	17.2	1.25
Common Stock	0.04	0.04	0.03	0.02	0.01	0.01
Additional Paid-In Capital	395.48	387.44	299.82	230.05	124.62	38.01
Retained Earnings	-308.85	-271.86	-160.08	-96.3	-55.93	-26.32
Total Common Equity	86.67	115.62	139.77	133.77	68.71	11.7
Shareholders' Equity	86.67	115.62	139.77	133.77	68.71	11.7
Total Liabilities & Equity	218.13	245.12	191.22	175.7	85.91	12.96
Total Debt	98.71	97.95	37.45	35.24	14.89	0.26
Net Cash (Debt)	106.98	137.15	143.14	133.35	69.42	11.4
Net Cash Growth	-23.44%	-4.18%	7.34%	92.08%	509.11%	-38.40%
Net Cash Per Share	2.56	3.48	6.04	8.65	5.19	1.11
Filing Date Shares Outstanding	37.87	37.84	30.45	21.69	14.92	10.3
Total Common Shares Outstanding	37.84	37.14	25.51	21.67	14.92	10.3
Working Capital	184.68	212.85	176.4	168.31	82.85	10.98
Book Value Per Share	2.29	3.11	5.48	6.17	4.61	1.14
Tangible Book Value	86.67	115.62	139.77	133.77	68.71	11.7
Tangible Book Value Per Share	2.29	3.11	5.48	6.17	4.61	1.14
Machinery	-	2.03	1.79	1.68	1.52	1.46
Leasehold Improvements	-	0.3	0.3	0.3	0.3	0.3

Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q